fluticasone furoate, umeclidinium and vilanterol

Action and Spectrum

Drug Interaction

Adverse Reaction

Adverse drug reactions:   

Frequency Defined  

>10%   

Nasopharyngitis  

1-10%  

Bronchitis   

Respiratory tract infection  

Back pain   

Urinary tract infection   

Influenza  

Sinusitis  

Headache  

Upper respiratory tract infection  

Pneumonia   

Dysphonia   

Oropharyngeal pain  

Black Box Warning

Contraindication / Caution

Pregnancy / Lactation

Pregnancy warnings:     

Pregnancy Category: N/A 

Lactation: unknown if distributed into breast milk, avoid 

Pregnancy Categories:       

Category A: Satisfactory and well-controlled studies show no risk to the fetus in the first or later trimester.       

Category B: No evidence shown of risk to the fetus found in animal reproduction studies, and there are not enough studies on pregnant women       

Category C: Adverse effects on the fetus found with evidence in animal reproduction studies and no adequate evidence for a result in humans must take care of potential risks in pregnant women       

Category D: adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.       

Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.       

Category N: There is no data available for the drug under this category 

Pharmacology

Adminstartion

Patient Information Leaflet

Patient Information Leaflet    

Generic Name: Fluticasone furoate and vilanterol 

Why do we use Fluticasone furoate and vilanterol? 

fluticasone furoate, umeclidinium, and vilanterol is a Beta2 Agonists, Corticosteroids. It is used to treat COPD and severe Asthma.